Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab Across Various Solid Tumors
Published: May 29th 2019 | Updated: October 23rd 2024
FDA Grants Fast Track Designation to Lasofoxifene for ER+, ESR1-Mutant Metastatic Breast Cancer
Published: March 4th 2022 | Updated: October 23rd 2024
Part 2: Factors for Selecting a Novel Hormonal Therapy for nmCRPC
Published: January 6th 2023 | Updated: October 23rd 2024
Bridging Options for CAR T-Cell Therapy in R/R DLBCL
Published: October 19th 2024 | Updated: October 23rd 2024
Revolutionizing CLL Care With Targeted and Cellular Therapies
Published: October 19th 2024 | Updated: October 23rd 2024
Zakharia Evaluates Available Combination Options for Non–Clear Cell RCC